177 related articles for article (PubMed ID: 27895888)
61. Complexation of CXCL12, FGF-2 and VEGF with Heparin Modulates the Protein Release from Alginate Microbeads.
Adrian E; Treľová D; Filová E; Kumorek M; Lobaz V; Poreba R; Janoušková O; Pop-Georgievski O; Lacík I; Kubies D
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769095
[TBL] [Abstract][Full Text] [Related]
62. A 'degradable' poly(vinyl alcohol) iron oxide nanoparticle hydrogel.
Bannerman AD; Li X; Wan W
Acta Biomater; 2017 Aug; 58():376-385. PubMed ID: 28499634
[TBL] [Abstract][Full Text] [Related]
63. Fabrication of a heparin-PVA complex hydrogel for application as a vascular access.
Negishi J; Nam K; Kimura T; Hashimoto Y; Funamoto S; Higami T; Fujisato T; Kishida A
J Biomed Mater Res B Appl Biomater; 2014 Oct; 102(7):1426-33. PubMed ID: 24574158
[TBL] [Abstract][Full Text] [Related]
64. Silk fibroin/poly(vinyl alcohol) photocrosslinked hydrogels for delivery of macromolecular drugs.
Kundu J; Poole-Warren LA; Martens P; Kundu SC
Acta Biomater; 2012 May; 8(5):1720-9. PubMed ID: 22285428
[TBL] [Abstract][Full Text] [Related]
65. Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin.
Tang DW; Yu SH; Ho YC; Mi FL; Kuo PL; Sung HW
Biomaterials; 2010 Dec; 31(35):9320-32. PubMed ID: 20863557
[TBL] [Abstract][Full Text] [Related]
66. Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems.
Nie T; Baldwin A; Yamaguchi N; Kiick KL
J Control Release; 2007 Oct; 122(3):287-96. PubMed ID: 17582636
[TBL] [Abstract][Full Text] [Related]
67. Poly(vinyl alcohol) Physical Hydrogels: Matrix-Mediated Drug Delivery Using Spontaneously Eroding Substrate.
Jensen BE; Dávila I; Zelikin AN
J Phys Chem B; 2016 Jul; 120(26):5916-26. PubMed ID: 26958864
[TBL] [Abstract][Full Text] [Related]
68. Polysaccharide-poly(ethylene glycol) star copolymer as a scaffold for the production of bioactive hydrogels.
Yamaguchi N; Kiick KL
Biomacromolecules; 2005; 6(4):1921-30. PubMed ID: 16004429
[TBL] [Abstract][Full Text] [Related]
69. Controlled release of basic fibroblast growth factor from gelatin hydrogel sheet improves structural and physiological properties of vein graft in rat.
Haraguchi T; Okada K; Tabata Y; Maniwa Y; Hayashi Y; Okita Y
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):548-55. PubMed ID: 17170380
[TBL] [Abstract][Full Text] [Related]
70. Spatiotemporal delivery of basic fibroblast growth factor to directly and simultaneously attenuate cardiac fibrosis and promote cardiac tissue vascularization following myocardial infarction.
Fan Z; Xu Z; Niu H; Sui Y; Li H; Ma J; Guan J
J Control Release; 2019 Oct; 311-312():233-244. PubMed ID: 31521744
[TBL] [Abstract][Full Text] [Related]
71. Perivascular extracellular matrix hydrogels mimic native matrix microarchitecture and promote angiogenesis via basic fibroblast growth factor.
Fercana GR; Yerneni S; Billaud M; Hill JC; VanRyzin P; Richards TD; Sicari BM; Johnson SA; Badylak SF; Campbell PG; Gleason TG; Phillippi JA
Biomaterials; 2017 Apr; 123():142-154. PubMed ID: 28167392
[TBL] [Abstract][Full Text] [Related]
72. Carboxyl-modified poly(vinyl alcohol)-crosslinked chitosan hydrogel films for potential wound dressing.
Zhang D; Zhou W; Wei B; Wang X; Tang R; Nie J; Wang J
Carbohydr Polym; 2015 Jul; 125():189-99. PubMed ID: 25857974
[TBL] [Abstract][Full Text] [Related]
73. Effect of heparin on pulmonary fibroblasts and vascular cells.
Yamashita Y; Nakagomi K; Takeda T; Hasegawa S; Mitsui Y
Thorax; 1992 Aug; 47(8):634-9. PubMed ID: 1412122
[TBL] [Abstract][Full Text] [Related]
74. Growth factor delivery from hydrogel particle aggregates to promote tubular regeneration after acute kidney injury.
Tsurkan MV; Hauser PV; Zieris A; Carvalhosa R; Bussolati B; Freudenberg U; Camussi G; Werner C
J Control Release; 2013 May; 167(3):248-55. PubMed ID: 23395667
[TBL] [Abstract][Full Text] [Related]
75. Deamidation of a model hexapeptide in poly(vinyl alcohol) hydrogels and xerogels.
Lai MC; Schowen RL; Borchardt RT; Topp EM
J Pept Res; 2000 Feb; 55(2):93-101. PubMed ID: 10784025
[TBL] [Abstract][Full Text] [Related]
76. Binding and release of basic fibroblast growth factor from heparinized collagen matrices.
Wissink MJ; Beernink R; Pieper JS; Poot AA; Engbers GH; Beugeling T; van Aken WG; Feijen J
Biomaterials; 2001 Aug; 22(16):2291-9. PubMed ID: 11456069
[TBL] [Abstract][Full Text] [Related]
77. Interactions of methacryloylated gelatin and heparin modulate physico-chemical properties of hydrogels and release of vascular endothelial growth factor.
Claaßen C; Southan A; Grübel J; Tovar GEM; Borchers K
Biomed Mater; 2018 Jul; 13(5):055008. PubMed ID: 29923498
[TBL] [Abstract][Full Text] [Related]
78. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
Mader JS; Smyth D; Marshall J; Hoskin DW
Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
[TBL] [Abstract][Full Text] [Related]
79. A First Step in De Novo Synthesis of a Living Pulp Tissue Replacement Using Dental Pulp MSCs and Tissue Growth Factors, Encapsulated within a Bioinspired Alginate Hydrogel.
Bhoj M; Zhang C; Green DW
J Endod; 2015 Jul; 41(7):1100-7. PubMed ID: 25958179
[TBL] [Abstract][Full Text] [Related]
80. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels.
Matsui M; Tabata Y
Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]